摘要:
The present invention relates to a ginseng mixed composition with improved bioavailability of saponin. Further, the present invention relates to a method for improving saponin bioavailability of a subject comprising: administering to the subject an effective amount of at least one extract selected from a Schizandra chinensis extract and a Liriope platyphylla extract that improves saponin bioavailability in the subject.
摘要:
The present invention relates to an antithrombotic composition containing a fraction of a colored-bean extract. The antithrombotic composition is highly useful for the treatment of diseases of the circulatory system, including cardiovascular disease, cerebrovascular disease, arteriosclerosis, hypertension and diabetes, which are caused by thrombosis.
摘要:
The present invention relates to novel thiourea derivatives as a modulator for vanilloid receptor (VR) and the pharmaceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pain, post-operative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurodegeneration, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, irritable bowel syndrome, a respiratory disorder such as asthma or chronic obstructive pulmonary disease, irritation of skin, eye or mucous membrane, fervescence, stomach-duodenal ulcer, inflammatory bowel disease and inflammatory diseases can be enumerated. The present invention provides a pharmaceutical composition for prevention or treatment of these diseases.
摘要:
Compounds of Formula I potently inhibit both cyclooxygenase-2 and carbonic anhydrases. Inhibition of carbonic anhydrases by a cyclooxygenase-2 inhibitor may affect significantly the safety and efficacy profiles of such a dual inhibitor in the treatment of cyclooxygenase-2 mediated disorders, compared to a cyclooxygenase-2 inhibitor without carbonic anhydrase inhibitory activity.
摘要:
An image forming apparatus includes a light source to emit a laser beam; a resonant scanning mirror, including a reflection surface to reflect the laser beam emitted from the light source, to scan the reflected laser beam by oscillating the reflection surface; at least one detector to detect the reflected laser beam during the scanning of the reflected laser beam, and generate a synchronizing signal each time the reflected laser beam is detected; and at least one light selection unit to restrict a path over which the reflected laser beam is incident on the at least one detector to a predetermined path.
摘要:
This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receotor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorder, urinary bladder hypersensitiveness, irritable bowel syndrome, fecal urgency, a respiratory disorder, irritation of skin, eye or mucous membrane, stomach-duodenal ulcer, inflammatory diseases, ear disease, and heart disease.
摘要:
A laser scanning unit scans a light beam onto a photoconductor to form a latent image. The laser scanning unit includes a light source that generates and radiates a light. A polygon mirror deflects and scans the light emitted from the light source. A driving motor drives and rotates the polygon mirror. A circuit substrate has a first surface on which the polygon mirror and the driving motor are coaxially mounted. A housing, to which the circuit substrate is coupled, includes an opening through which the polygon mirror is introduced in the inner space. A second surface of the circuit substrate to the opposite side of the polygon mirror is entirely exposed to the outside to function as a heat radiation surface. Thus, the heat dissipation characteristic of heating dissipation components, including a driving motor, is improved and the inner sealing of the laser scanning unit is secured.
摘要:
Disclosed is a novel compound acting as a cannabinoid receptor 1 inhibitor, a prodrug thereof, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel compound or the like is useful for preventing or treating diseases mediated by the cannabinoid receptor-1.